Trial intelligence / Profile preview

Citrupress in children undergoing cardiopulmonary bypass

NCT01120964Phase 2Completed

Sponsor
Asklepion Pharmaceuticals
Start
Sep 2010
Primary completion
Apr 2012
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of citrulline in pulmonary hypertension (PH), acute lung injury (ALI), sponsored by Asklepion Pharmaceuticals. Started Sep 2010; status: completed.

02

Drugs

citrulline
03

Conditions

pulmonary hypertension (PH)acute lung injury (ALI)

Beyond the preview

Go deeper on NCT01120964.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01120964.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call